Sartorius Stedim Biotech postpones Annual Shareholders’ Meeting

Version française

Sartorius Stedim Biotech S.A. will postpone its Annual General Shareholders’ Meeting formerly scheduled for March 24, 2020, to a later date due to the coronavirus pandemic and the associated restrictions imposed on travel and meetings. This was resolved today by the Board of Directors of the company.

As a result of the cancelation of the Annual General Shareholders’ Meeting on March 24, 2020, the vote on the resolution on the assignment of the financial result for the year ended December 31, 2019, and the payment of dividends, among other things, will also be deferred.

The 2020 Annual General Shareholders’ Meeting is to be scheduled for a new date within six months after the close of the fiscal year ending on December 31, 2019 as provided for under the French Commercial Law. Sartorius Stedim Biotech will inform its shareholders and the public in a timely manner about its further planning.

Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.